3 symptoms of cancer that appear in the face - from lung to skin cancer
There are more than 200 different types of cancer and experts say there are some early warning signs people are "most likely ...
Cure Today4d
Why Clinical Trials Don’t Have to Be Patients’ ‘Last Line of Defense’
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...
Pharmabiz19h
Leads Biolabs receives US FDA orphan drug designation for anti-PD-L1/4-1BB bispecific antibody, LBL-024 for treatment of neuroendocrine cancer
Leads Biolabs receives US FDA orphan drug designation for anti-PD-L1/4-1BB bispecific antibody, LBL-024 for treatment of neuroendocrine cancer: Nanjing, China Saturday, November 2 ...
The Daily Item11d
UPMC Pulmonologist: Annual lung screening recommended for high-risk individuals
One in 16 Americans will be diagnosed with lung cancer in their lifetime. As the leading cause of cancer deaths in the U.S., ...
FierceBiotech12d
23andMe shutters cancer drug research programs, lays off 40% of staff
It’s being examined in a phase 1/2a study designed to enroll up to 15 patients for each of six different cohorts, spanning ...
Combination approach shows promise for treating rare, aggressive cancers
A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...
Future Market Insights9d
Global Neuroendocrine Carcinoma Treatment Market to Reach USD 4,305.7 Million by 2034 at a 8.1% of CAGR
The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...
FierceBiotech5d
Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks
Novartis is adding another radiopharmaceutical program to its collection, penning a deal worth $745 million in biobucks for ...